Sign Up to like & get recommendations! 0
Published in 2021 at "Reviews in medical virology"
DOI: 10.1002/rmv.2220
Abstract: Human polyomaviruses (HPyVs) encompass more than 10 species infecting 30%-90% of the human population without significant illness. Proven HPyV diseases with documented histopathology affect primarily immunocompromised hosts with manifestations in brain, skin and renourinary tract… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Clinical Transplantation"
DOI: 10.1111/ctr.14785
Abstract: BK polyomavirus‐associated nephropathy (BKPyVAN) carries a risk of irreversible allograft injury. While detection of BK viremia and biopsy assessment are the current diagnostic gold standard, the diagnostic value of biomarkers reflecting tissue injury (donor‐derived cell‐free… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Transplant Infectious Disease"
DOI: 10.1111/tid.12939
Abstract: Evolving BK polyomavirus–associated nephropathy (BKPyVAN) is characterized by tubulointerstitial inflammation that closely resembles acute T‐cell–mediated allograft rejection if tubulitis is significant. The cellular composition of the inflammation varies during the course of BKPyVAN, and clusters… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Transplant Infectious Disease"
DOI: 10.1111/tid.13228
Abstract: Polyomavirus‐associated nephropathy (PVAN) remains a relevant complication following kidney transplantation with allograft loss rates of up to 50%. Reduction in overall immunosuppression is a cornerstone of therapy, whereas no specific antiviral regimen has shown conclusive… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Transplant Infectious Disease"
DOI: 10.1111/tid.13557
Abstract: There is still a lack of a recognized morphological classification of BK viral nephropathy (BKVN) which can better reflect the clinical manifestations and prognosis. read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "BMJ Case Reports"
DOI: 10.1136/bcr-2025-268414
Abstract: This report describes a man in his late 50s who underwent donation-after-circulatory-death kidney transplantation in 2012, due to end-stage kidney disease of unknown origin. More than a decade post-transplant, he presented with a progressive decline… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2021.791087
Abstract: Introduction: The absolute BK viral load is an important diagnostic surrogate for BK polyomavirus associated nephropathy (PyVAN) after renal transplant (KTX) and serial assessment of BK viremia is recommended. However, there is no data indicating… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Biomolecules"
DOI: 10.3390/biom14030348
Abstract: Mitochondria are essential organelles that possess their own DNA. Mitochondrial dysfunction has been revealed in many kidney diseases, including BK polyomavirus-associated nephropathy (BKPyVAN). In this study, we introduce an innovative approach for non-invasive monitoring of… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Viruses"
DOI: 10.3390/v17091256
Abstract: The reactivation of BK polyomavirus (BKPyV) during severe immunosuppression plays a crucial role in two significant syndromes observed in transplant recipients: BK polyomavirus-associated nephropathy (BKPyVAN) in kidney transplant patients and BK polyomavirus-associated hemorrhagic cystitis (BKPyV-HC)… read more here.